Livongo's beyond diabetes revenue. Fitbit loses exec to CVS-Aetna

Issue 018.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 78 percent open rate. Here's what's happening this week:

I've been studying all things Pear Therapeutics these past few weeks. If you have any tips, leads, or insights on this ambitious company, please send them over. Must-read report on them coming your way next week.
CVS/Aetna poached Fitbit's SVP and GM Adam Pellegrini as its new head of consumer health. Pellegrini was Fitbit's top exec focused on moving the company into healthcare. He helped Fitbit get into FDA's Pre-Cert program and led the acquisition of Twine Health, which became Fitbit Care. Pellegrini previously held a lead digital health role at Walgreens. CNBC has other details in its story here.
Ginger, which I'm learning no longer calls itself Ginger.io, announced a $35M Series C this week led by

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Livongo’s beyond diabetes revenue. Fitbit loses exec to CVS-Aetna

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

Livongo’s beyond diabetes revenue. Fitbit loses exec to CVS-Aetna

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.